These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 7592630

  • 1. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
    Feng XH, Filvaroff EH, Derynck R.
    J Biol Chem; 1995 Oct 13; 270(41):24237-45. PubMed ID: 7592630
    [Abstract] [Full Text] [Related]

  • 2. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
    Vivien D, Attisano L, Wrana JL, Massagué J.
    J Biol Chem; 1995 Mar 31; 270(13):7134-41. PubMed ID: 7706250
    [Abstract] [Full Text] [Related]

  • 3. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun 31; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 4. Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription.
    Brand T, Schneider MD.
    J Biol Chem; 1995 Apr 07; 270(14):8274-84. PubMed ID: 7713935
    [Abstract] [Full Text] [Related]

  • 5. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR, Schreiber SL.
    Curr Biol; 1998 Jun 18; 8(13):761-70. PubMed ID: 9651680
    [Abstract] [Full Text] [Related]

  • 6. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest.
    Zwaagstra JC, Guimond A, O'Connor-McCourt MD.
    Exp Cell Res; 2000 Jul 10; 258(1):121-34. PubMed ID: 10912794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
    Kim TK, Mo EK, Yoo CG, Lee CT, Han SK, Shim YS, Kim YW.
    Lung Cancer; 2001 Jul 10; 31(2-3):181-91. PubMed ID: 11165397
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H.
    J Biol Chem; 1996 Feb 02; 271(5):2769-75. PubMed ID: 8576253
    [Abstract] [Full Text] [Related]

  • 11. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
    Wang J, Sergina N, Ko TC, Gong J, Brattain MG.
    J Biol Chem; 2004 Sep 17; 279(38):40237-44. PubMed ID: 15271980
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
    Wieser R, Attisano L, Wrana JL, Massagué J.
    Mol Cell Biol; 1993 Dec 17; 13(12):7239-47. PubMed ID: 8246946
    [Abstract] [Full Text] [Related]

  • 14. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB, Moody TW, You L, Mariano JM.
    Mol Carcinog; 1998 May 17; 22(1):46-56. PubMed ID: 9609100
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H, Ueno H, Ooshima A, Takeshita A.
    J Biol Chem; 1996 Jul 05; 271(27):16253-9. PubMed ID: 8663151
    [Abstract] [Full Text] [Related]

  • 16. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7.
    Quan T, He T, Voorhees JJ, Fisher GJ.
    J Biol Chem; 2001 Jul 13; 276(28):26349-56. PubMed ID: 11320083
    [Abstract] [Full Text] [Related]

  • 17. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 18. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ, Ward-van Oostwaard D, Wianny F, Savatier P, Zwijsen A, Mummery C.
    Differentiation; 1998 Jul 21; 63(3):101-13. PubMed ID: 9697304
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JK, Sun L, Brattain MG.
    J Biol Chem; 1996 Jul 19; 271(29):17366-71. PubMed ID: 8663343
    [Abstract] [Full Text] [Related]

  • 20. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.